Furthermore, proteasome inhibition suppresses necroptosis competency, as shown in TNFα/zVAD-fmk/IAP antagonist treated macrophages and HT29 colon cancer cells [41, 42]. This evidence concerns the gene TNF and malignant colon neoplasm.